reminded of past, current and or future associatio
Post# of 9144
Posted On: 06/15/2015 1:14:53 PM
reminded of past, current and or future associations it makes one wonder under what association(s) or agreement w NNLX -if any- the ''recent and ongoing work [by] researchers'' is or was being conducted
if an NDA or JV is in play re such research that would explain why the purposefully vague wording of ''researchers'' was used rather than directly attributing such research to a NNLX in-house lab
I've seen penny CEO's keep a really tight lip re such associations until an announcement is approved by both parties although they have to be chomping at the bit to reveal such in the midst of all the bashing milieu so common to pennies
follow up QA work was obviously being done
also its possible-in addition to the patents in the pipeline coming to fruition-that Gwens on board retainer services may not be needed as much with the existence of an NDA/JV possibly increasingly handling of any such work by JV partners. Just rational possibilities rather than the constant flailing at the wind re any possibilities by bashers
one of the benefits of my purposefully avoiding any NNLX insider knowledge in a no info co is my freedom to speculate or draw the dots -as you have done-while others who may have much more knowledge re these things are forced to remain silent- also chafing at bashers without being able to respond due to NDA's
Jan, 2015 NanoLogix is pleased to share the following information:
In recent and ongoing work, researchers in the United States have confirmed the potential efficacy of NanoLogix's N-Assay as a rapid indicator for the presence of the current-threat strain of the Ebola virus, EBOV. The research demonstrates a sub-three hour result at present. Researchers are working to refine the test and reduce time-to-detection to facilitate the N-Assay's use as a Point of Care (POC) diagnostic for hemorrhagic and other viruses.
if an NDA or JV is in play re such research that would explain why the purposefully vague wording of ''researchers'' was used rather than directly attributing such research to a NNLX in-house lab
I've seen penny CEO's keep a really tight lip re such associations until an announcement is approved by both parties although they have to be chomping at the bit to reveal such in the midst of all the bashing milieu so common to pennies
follow up QA work was obviously being done
also its possible-in addition to the patents in the pipeline coming to fruition-that Gwens on board retainer services may not be needed as much with the existence of an NDA/JV possibly increasingly handling of any such work by JV partners. Just rational possibilities rather than the constant flailing at the wind re any possibilities by bashers
one of the benefits of my purposefully avoiding any NNLX insider knowledge in a no info co is my freedom to speculate or draw the dots -as you have done-while others who may have much more knowledge re these things are forced to remain silent- also chafing at bashers without being able to respond due to NDA's
Jan, 2015 NanoLogix is pleased to share the following information:
In recent and ongoing work, researchers in the United States have confirmed the potential efficacy of NanoLogix's N-Assay as a rapid indicator for the presence of the current-threat strain of the Ebola virus, EBOV. The research demonstrates a sub-three hour result at present. Researchers are working to refine the test and reduce time-to-detection to facilitate the N-Assay's use as a Point of Care (POC) diagnostic for hemorrhagic and other viruses.
(0)
(0)